Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer

The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer

(2014) Takayuki Goto et al.   PLoS One

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer

(2013) Masahiro Kawashima et al.   CANCER SCIENCE

Accumulated phosphatidylcholine (16:0/16:1) in human colorectal cancer; possible involvement of LPCAT4

(2013) Nobuya Kurabe et al.   CANCER SCIENCE

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays

(2013) Stefan Steurer et al.   INTERNATIONAL JOURNAL OF CANCER

Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression

(2013) Yoshifumi Morita et al.   JOURNAL OF HEPATOLOGY

MALDI-MS tissue imaging identification of biliverdin reductase B overexpression in prostate cancer

(2013) Johannes Dominikus Pallua et al.   Journal of Proteomics

High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

(2013) Katharina Grupp et al.   Molecular Oncology

The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution

(2013) Masahiro Yasunaga et al.   Scientific Reports

Interactive hyperspectral approach for exploring and interpreting DESI-MS images of cancerous and normal tissue sections

(2012) Valentina Pirro et al.   ANALYST

Single Cell Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging

(2012) Yvonne Schober et al.   ANALYTICAL CHEMISTRY

Lipid metabolism in cancer

(2012) Claudio R. Santos et al.   FEBS Journal

How cancer metabolism is tuned for proliferation and vulnerable to disruption

(2012) Almut Schulze et al.   NATURE

Increased Expression of Phosphatidylcholine (16:0/18:1) and (16:0/18:2) in Thyroid Papillary Cancer

(2012) Seiji Ishikawa et al.   PLoS One

Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics

(2012) Xinchun Zhou et al.   PLoS One

Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer

(2011) David Bonnel et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Visualization of phosphatidylcholine, lysophosphatidylcholine and sphingomyelin in mouse tongue body by matrix-assisted laser desorption/ionization imaging mass spectrometry

(2011) Hirofumi Enomoto et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice

(2011) Akiko Kubo et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

MALDI Imaging of Lipid Biochemistry in Tissues by Mass Spectrometry

(2011) Karin A. Zemski Berry et al.   CHEMICAL REVIEWS

The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer

(2011) Xinchun Zhou et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Cyr61 is regulated by cAMP-dependent protein kinase with serum levels correlating with prostate cancer aggressiveness

(2011) Naoki Terada et al.   PROSTATE

Ultrahighly Sensitive in Situ Metabolomic Imaging for Visualizing Spatiotemporal Metabolic Behaviors

(2010) Daisuke Miura et al.   ANALYTICAL CHEMISTRY

Cholesterol Sulfate Imaging in Human Prostate Cancer Tissue by Desorption Electrospray Ionization Mass Spectrometry

(2010) Livia S. Eberlin et al.   ANALYTICAL CHEMISTRY

De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation

(2010) E. Rysman et al.   CANCER RESEARCH

Imaging mass spectrometry revealed the production of lyso-phosphatidylcholine in the injured ischemic rat brain

(2010) S. Koizumi et al.   NEUROSCIENCE

Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression

(2009) Mohammed Ahmed Abdel Muneem Nouh et al.   CANCER SCIENCE

Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue

(2009) L. H. Cazares et al.   CLINICAL CANCER RESEARCH

Organ-Specific Distributions of Lysophosphatidylcholine and Triacylglycerol in Mouse Embryo

(2009) Takahiro Hayasaka et al.   LIPIDS

High-fat diet, obesity and prostate disease: the ATX–LPA axis?

(2009) Prakash Kulkarni et al.   Nature Reviews Urology

Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study

(2008) Roy Vergis et al.   LANCET ONCOLOGY

Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia

(2008) Yu Zeng et al.   PROSTATE

Matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight (MALDI-QIT-TOF)-based imaging mass spectrometry reveals a layered distribution of phospholipid molecular species in the mouse retina

(2008) Takahiro Hayasaka et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Lipid Alterations in Transient Forebrain Ischemia

(2003) A. Muralikrishna Rao et al.   JOURNAL OF NEUROCHEMISTRY